Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

This year. We're going Beyond.

Why PolyNovo (ASX:PNV) shares are on watch this morning

PolyNovo (ASX: PNV) shares are on watch this morning after releasing an FY20 trading update.

What is PolyNovo?

PolyNovo is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb BTM biodegradable polymer technology.

Trading update

The company said that June 2020 was a new sales record month in the US. Over the past three months the company has opened seven new hospital accounts. In FY20 there has been a 67% increase in the hospital account in the US.

PolyNovo has achieved its first sale in the UK. There have been six operations in England and Scotland. Management are now expecting additional new term sales.

In the EU there have been “numerous” applications of BTM in Germany, Austria and Switzerland. Sales are growing as it expands in the region.

Some numbers from PolyNovo

Management reaffirmed earlier guidance that product sales for FY20 are likely to at least double FY19’s total.

Sales for the June quarter were 33% higher than the March quarter. This includes the record US result.

Management comments

PolyNovo Managing Director Paul Brennan said: “These sales results for NovoSorb BTM are very strong given the difficulties faced with COVID-19. Our teams have maintained their engagement with customers and we continue to see sales growth.”

PolyNovo Chairman David Williams said: “Sales are still lumpy but there is a strong upward trajectory as surgeons embrace our product and the patient results it gives. While FY20 sales will show impressive growth over FY19, the sales run-rate is more impressive and should be a better indicator of the near-term future.”

Summary

This is clearly good business growth and points to a promising next 12 months. I like to see ASX companies grow well internationally. I don’t know enough about the share yet to know if today’s PolyNovo share price is a buy, but it’s a business I’m going to follow with interest. One ASX share I like for international growth is Bubs (ASX: BUB).

Got $1,000? Try our #1 growth stock...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Got $1,000? Try this...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: